Clinical trial
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who…
NCT00149916 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00149916 |
|---|---|
| Title | Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107 |
| Official title | Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Patients. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Transplant |
| Intervention type | Drug |
| Interventions | Mycophenolate sodium (enteric coated) |
| Enrollment | 139 |
| Start date | Apr 1, 2000 |
| Primary completion | Apr 1, 2004 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: